Nanomaterials/Nanocarriers for Drug Delivery for Application in Cancer Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".
Deadline for manuscript submissions: closed (30 January 2024) | Viewed by 1888
Special Issue Editors
2. LABBELS-Associate Laboratory, 4710-057 Braga, Portugal
Interests: biosurfactants; bioactive molecules; adhesion and biofilms; synthetic biology; industrial biotechnology; bioprocess development; functional food and biomarkers
Special Issues, Collections and Topics in MDPI journals
2. LABBELS-Associate Laboratory, 4710-057 Braga, Portugal
Interests: biosurfactants; synthetic biology; industrial biotechnology; bioprocess development; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Conventional chemotherapy is widely used to eradicate tumor cells through several different mechanisms, aiming to kill growing cells, which includes both tumor and normal cells. This causes serious side effects such as bone marrow suppression, gastrointestinal perturbations, and hair loss. Another main hindrance in tumor management is the development of drug resistance. As cancer remains the second leading cause of death worldwide, more studies and research are needed to overcome the abovementioned limitations of chemotherapy.
In recent years, unprecedented novel nanocarriers/nanostructures have emerged and been exploited with the purpose of delivering drugs at the desired sites with reduced side effects and with a potential pharmacological response. These nanocarrier-based drug delivery systems are being used against several types of malignant tumors. Moreover, different types of nanocarriers have been successfully adopted in various nanomedicines, usually designed according to the pathophysiology of the tumors.
This Special Issue of the International Journal of Molecular Sciences, entitled “Nanomaterials/Nanocarriers for Drug Delivery for Application in Cancer Therapy”, welcomes the submission of original articles or reviews on the use of nanoparticles to precisely deliver drugs during cancer treatment, addressing the potential and limitations of such systems, highlighting novel treatment trends, and assessing mechanisms of action. Topics of interest for this Special Issue include, but are not limited to, the following:
- Synthesis strategies and methodologies of novel nanomaterials;
- Characterization of the properties of novel nanocarriers;
- Studies regarding drug loading and release from nanocarriers;
- Mechanisms underlying the nanocarriers in vivo;
- Targeted/modified nanocarriers as delivery vehicles.
Dr. Lígia R. Rodrigues
Dr. Debora Ferreira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
